Hydrogen therapy may be an effective and specific novel treatment for acute graft-versus-host disease (GVHD).
Liren Qian, Jianliang Shen · Journal of cellular and molecular medicine · 2013
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In mice, the authors' recent studies provided evidence that hydrogen inhalation can selectively reduce cytotoxic oxygen radicals and exert antioxidant effects. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how inhaled hydrogen gas affected the outcomes measured in mice. The authors' recent studies provided evidence that hydrogen inhalation can selectively reduce cytotoxic oxygen radicals and exert antioxidant effects.
What the Researchers Studied
The researchers studied mice. The study used a preclinical animal experiment.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen concentration: 97.5% source-reported H₂ gas concentration; Source-reported hydrogen exposure: 97.5% source-reported H₂ gas concentration; reported treatment duration: 2 weeks. The authors' recent studies provided evidence that hydrogen inhalation can selectively reduce cytotoxic oxygen radicals and exert antioxidant effects. The authors concluded that suggested that hydrogen may have therapeutic effects on aGVHD.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was mice. The study used a preclinical animal experiment. The hydrogen delivery method was inhaled hydrogen gas. The source-reported hydrogen concentration was 97.5% source-reported H₂ gas concentration. The reported treatment duration was 2 weeks.
Limitations and Safety
Safety information: TESTING THE HYPOTHESIS: For testing the hypothesis, hydrogen gas could be administered by two ways: First, it may be administered to patients via inhalation as room air at safe concentrations (<4.6% in air by volume).
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.